Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.7.3319

Relationship Between the Prohibitin 3' Untranslated Region C > T Gene Polymorphism and Cancer Susceptibility - Results of a Meta-analysis  

Zhou, Tian-Biao (Department of Experimental Pathology, The Affiliated Tumor Hospital of Guangxi Medical University)
Yin, Sheng-Sheng (Department of Pediatric Nephrology, The First Affiliated Hospital of GuangXi Medical University)
Huang, Jian-Jian (Department of Otorhinolaryngology, Taihe Hospital of Hubei University of Medicine)
Ou, Chao (Department of Experimental Pathology, The Affiliated Tumor Hospital of Guangxi Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.7, 2012 , pp. 3319-3323 More about this Journal
Abstract
Objective: The results from the published studies on the association between prohibitin 3' untranslated region C > T gene polymorphism and cancer risk are conflicting. This meta-analysis was performed to evaluate the relationship with cancer susceptibility overall, and to explore whether the T allele or TT genotype could become a predictive marker for cancer risk. Methods: Association studies were identified from the databases of PubMed, Embase, and Cochrane Library as of March 1, 2012, and eligible investigations were synthesized using the meta-analysis method. Results were expressed with odds ratios (OR) for dichotomous data, and 95% confidence intervals (CI) were also calculated. Results: Six investigations were identified for the analysis of association between the prohibitin 3' untranslated region C > T gene polymorphism and cancer risk, covering of 1,461 patients with cancer and 1,197 controls. There was a positive association between the T allele and cancer susceptibility (OR=1.20, 95% CI: 1.03-1.39, P=0.02), and CC homozygous might play a protective role (OR=0.80, 95% CI: 0.68-6.11, P=0.95). In the sub-group analysis, prohibitin 3' untranslated region C > T gene polymorphism and cancer risk appeared associated with the risk of breast cancer, but not ovarian cancer. Conclusions: Our results indicate that T allele is a significant genetic molecular marker to predict cancer susceptibility and CC genotype is protective, especially for breast cancer. However, more investigations are required to further clarify the association of the prohibitin 3' untranslated region C > T gene polymorphism with cancer susceptibility.
Keywords
Prohibitin; 3' untranslated region; C > T gene polymorphism; ovarian cancer; breast cancer; meta-analysis;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Alshatwi AA, Shafi G, Hasan TN, et al (2011). Apoptosis-mediated inhibition of human breast cancer cell proliferation by lemon citrus extract. Asian Pac J Cancer Prev, 12, 1555-9.
2 Altus MS, Wood CM, Stewart DA, et al (1995). Regions of evolutionary conservation between the rat and human prohibitin-encoding genes. Gene, 158, 291-4.   DOI
3 Arisawa T, Tahara T, Shiroeda H, et al (2012). Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3'-UTR, influence susceptibility to gastric cancer. Hum Immunol, 73, 747-52.   DOI
4 Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.   DOI
5 Campbell IG, Allen J, Eccles DM (2003). Prohibitin 3' untranslated region polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 12, 1273-4.
6 Egger M, Davey SG, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI
7 Gao CM, Tajima K, Ding JH, et al (2009). Body size, physical activity and risk of breast cancer - a case control study in Jangsu Province of China. Asian Pac J Cancer Prev, 10, 877-81.
8 Gao S, Liu N, Ma Y, et al (2012). Methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers in ovarian cancer risk. Asian Pac J Cancer Prev, 13, 569-73.   과학기술학회마을   DOI   ScienceOn
9 Grimm C, Polterauer S, Zeillinger R, et al (2008). The prohibitin 3' untranslated region polymorphism in patients with ovarian cancer. Eur J Obstet Gynecol Reprod Biol, 137, 236-9.   DOI
10 Huo X, Lu C, Huang X, et al (2009). Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women. J Cancer Res Clin Oncol, 135, 1569-75.   DOI
11 Jakubowska A, Gronwald J, Gorski B, et al (2007). The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation. Breast Cancer Res Treat, 104, 67-74.   DOI
12 Jakubowska A, Gronwald J, Menkiszak J, et al (2008). Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism. BMC Cancer, 8, 90.   DOI
13 Jeon S, Choi JY, Lee KM, et al (2010). Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer. Breast Cancer Res Treat, 121, 737-42.   DOI
14 Jeschke J, Van Neste L, Glockner SC, et al (2012). Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen. Epigenetics, 7, 7.
15 Karakus N, Kara N, Ulusoy AN (2008). Lack of association between prohibitin 3' untranslated region C-->T polymorphism and breast cancer in a Turkish population. DNA Cell Biol, 27, 449-52.   DOI
16 Kermani IA, Kojidi HT, Gharamaleki JV, et al (2011). Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer. Asian Pac J Cancer Prev, 12, 1381-4.
17 Khokher S, Qureshi MU, Riaz M, Akhtar N, Saleem A (2012). Clinicopathologic profile of breast cancer patients in pakistan: ten years data of a local cancer hospital. Asian Pac J Cancer Prev, 13, 693-8.   과학기술학회마을   DOI   ScienceOn
18 Manjeshwar S, Branam DE, Lerner MR, et al (2003). Tumor suppression by the prohibitin gene 3'untranslated region RNA in human breast cancer. Cancer Res, 63, 5251-6.
19 Li QF, Liang Y, Shi SL, et al (2011). Localization of prohibitin in the nuclear matrix and alteration of its expression during differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid. Cell Mol Neurobiol, 31, 203-11.   DOI
20 Luparello C, Longo A, Vetrano M (2012). Exposure to cadmium chloride influences astrocyte-elevated gene-1 (AEG-1) expression in MDA-MB231 human breast cancer cells. Biochimie, 94, 207-13.   DOI
21 Nadimpalli R, Yalpani N, Johal GS, et al (2000). Prohibitins, stomatins, and plant disease response genes compose a protein superfamily that controls cell proliferation, ion channel regulation, and death. J Biol Chem, 275, 29579-86.   DOI
22 Sagae S, Mori M, Moore MA (2002). Risk Factors for Ovarian Cancers: Do Subtypes Require Separate Treatment in Epidemiological Studies? Asian Pac J Cancer Prev, 3, 5-16.
23 Spurdle AB, Purdie DM, Chen X, et al (2003). The prohibitin 3' untranslated region polymorphism is not associated with risk of ovarian cancer. Gynecol Oncol, 90, 145-9.   DOI
24 Szabova L, Yin C, Bupp S, et al (2012). Perturbation of Rb, p53 and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer. Cancer Res, doi: 10.1158/0008-5472.CAN-11-3834.   DOI
25 Vijayaraman KP, Veluchamy M, Murugesan P, et al (2012) p53 Exon 4 (codon 72) Polymorphism and Exon 7 (codon 249) Mutation in Breast Cancer Patients in Southern Region (Madurai) of Tamil Nadu. Asian Pac J Cancer Prev, 13, 511-6.   과학기술학회마을   DOI   ScienceOn
26 Yip CH, Anderson BO (2007). The Breast Health Global Initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries. Expert Rev Anticancer Ther, 7, 1095-104.   DOI
27 Wang T, Li QH, Hao GP, et al (2010). Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo. Asian Pac J Cancer Prev, 11, 193-200.
28 Xu L, Ju XB, Li P, et al (2012) Association Between the Ku70-1310C/G Promoter Polymorphism and Cancer Risk: a Meta-analysis. Asian Pac J Cancer Prev, 13, 683-7.   과학기술학회마을   DOI
29 Xu X, Ren H, Zhou B, et al (2012). Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients. Lung Cancer, 77, 438-42.   DOI
30 Yip CH, Taib NA, Choo WY, et al (2009). Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCA-associated breast cancers in a multiracial developing country. World J Surg, 33, 2077-81.   DOI
31 Yip CH, Taib NA, Mohamed I (2006). Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev, 7, 369-74.
32 Zhang Y, Xu B, Liu Y, et al (2012). The ovarian cancer-derived secretory/releasing proteome: a repertoire of tumor markers. Proteomics, 12, 1883-91.   DOI
33 Zhou TB, Liu YG, Lin N, et al (2012). Relationship Between Angiotensin-converting Enzyme Insertion/Deletion Gene Polymorphism and Systemic Lupus Erythematosus/Lupus Nephritis: A Systematic Review and Metaanalysis. J Rheumatol, 39, 686-93.   DOI
34 Zhou TB, Qin YH, Su LN, et al (2011). The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst, 12, 624-33.   DOI
35 Zhou TB, Qin YH, Su LN, et al (2011). ACE I/D gene polymorphism can't predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: a meta-analysis. PLoS One, 6, 19599.   DOI
36 Zhou TB, Qin YH, Su LN, et al (2011). Insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene in steroid-resistant nephrotic syndrome for children: a genetic association study and meta-analysis. Ren Fail, 33, 741-8.   DOI